JP2005535635A5 - - Google Patents

Download PDF

Info

Publication number
JP2005535635A5
JP2005535635A5 JP2004517161A JP2004517161A JP2005535635A5 JP 2005535635 A5 JP2005535635 A5 JP 2005535635A5 JP 2004517161 A JP2004517161 A JP 2004517161A JP 2004517161 A JP2004517161 A JP 2004517161A JP 2005535635 A5 JP2005535635 A5 JP 2005535635A5
Authority
JP
Japan
Prior art keywords
organosulfur compound
compound
composition
relative
preferred
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004517161A
Other languages
English (en)
Other versions
JP2005535635A (ja
Filing date
Publication date
Priority claimed from DE10228680A external-priority patent/DE10228680A1/de
Application filed filed Critical
Publication of JP2005535635A publication Critical patent/JP2005535635A/ja
Publication of JP2005535635A5 publication Critical patent/JP2005535635A5/ja
Pending legal-status Critical Current

Links

Description

好ましい態様において、治療的に活性な化合物および/または栄養素の経皮投与のための組成物は、有機硫黄化合物をさらに含む。
有機硫黄化合物は、好ましくは、非油性エマルジョンに対して2〜30%(w/v)の量で、より好ましくは4〜25%(w/v)の量で存在する。
JP2004517161A 2002-06-27 2003-06-21 経皮的組成物用プラットフォーム(ptf) Pending JP2005535635A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10228680A DE10228680A1 (de) 2002-06-27 2002-06-27 Grundlage für transdermale Formulierungen (PTF)
PCT/IB2003/003467 WO2004002444A2 (en) 2002-06-27 2003-06-21 A platform for transdermal formulations (ptf)

Publications (2)

Publication Number Publication Date
JP2005535635A JP2005535635A (ja) 2005-11-24
JP2005535635A5 true JP2005535635A5 (ja) 2006-05-11

Family

ID=29761469

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004517161A Pending JP2005535635A (ja) 2002-06-27 2003-06-21 経皮的組成物用プラットフォーム(ptf)

Country Status (14)

Country Link
US (1) US20050118241A1 (ja)
EP (1) EP1515706A2 (ja)
JP (1) JP2005535635A (ja)
KR (1) KR20050027995A (ja)
CN (1) CN1665492A (ja)
AR (1) AR040287A1 (ja)
AU (1) AU2003252459A1 (ja)
CA (1) CA2490022A1 (ja)
DE (1) DE10228680A1 (ja)
MX (1) MXPA04012732A (ja)
MY (1) MY157852A (ja)
TW (1) TW200500093A (ja)
WO (1) WO2004002444A2 (ja)
ZA (1) ZA200500710B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033998B2 (en) * 2003-04-11 2006-04-25 All Natural Fmg, Inc. Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
US7582612B2 (en) * 2004-03-12 2009-09-01 Hartz Mountain Corporation Multi-action anthelmintic formulations
US10042980B2 (en) 2005-11-17 2018-08-07 Gearbox Llc Providing assistance related to health
US10296720B2 (en) 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
WO2010132562A2 (en) * 2009-05-12 2010-11-18 Ohio University Transdermal delivery of metformin
CA2763040C (en) * 2009-06-05 2018-05-01 Joan M. Caron Methods and compositions for the treatment of cancer
WO2014022414A1 (en) * 2012-07-30 2014-02-06 Coordinated Program Development, Llc Cochleates made with soy phosphatidylserine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4878892A (en) * 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
FR2616333A1 (fr) * 1987-06-12 1988-12-16 Cird Procede d'ionophorese pour administrer une substance dissoute ou partiellement dissoute, par voie percutanee ou perungueale et dispositif correspondant
JPS63316737A (ja) * 1987-06-19 1988-12-26 Toyo Jozo Co Ltd 経鼻投与用医薬組成物
IT1223343B (it) * 1987-11-03 1990-09-19 Also Lab Sas Formulazioni farmaceutiche per somministrazione transdermica
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
EP0429842B1 (en) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US5073539A (en) * 1990-01-22 1991-12-17 Ciba-Geigy Corporation Transdermal administration of zwitterionic drugs
NZ243721A (en) * 1991-07-26 1994-11-25 Smithkline Beecham Corp Self-emulsifying microemulsion comprising water soluble drug, high hlb surfactant and a lipophilic phase containing fatty acid triglyceride and a low hlb surfactant
FR2687321B1 (fr) * 1992-02-14 1999-04-16 Elf Aquitaine Dispositif d'ionophorese pour l'administration transcutanee d'une quantite totale donnee d'un principe actif a un sujet.
EP0739644A4 (en) * 1994-09-30 1998-12-09 Advance Kk INTERFACE FOR A TRANSDERMAL IONTOPHORETIC DEVICE AND CORRECT MEDICINE
US5707641A (en) * 1994-10-13 1998-01-13 Pharmaderm Research & Development Ltd. Formulations comprising therapeutically-active proteins or polypeptides
US5759445A (en) * 1995-05-24 1998-06-02 Matsushita Electric Industrial Co., Ltd. Lipid-dispersed solution and process for producing the same
US6183758B1 (en) * 1998-01-29 2001-02-06 Highland Laboratories, Inc. Phytochemicals, nutrients & medication absorption &/or treatment
PT1094781E (pt) * 1998-07-07 2008-10-08 Transdermal Technologies Inc Composições para administração transdérmica rápida e não irritante de agentes farmacologicamente activos e métodos para formulação de tais composições e sua administração
MXPA01011343A (es) * 1999-05-07 2002-06-04 Pharmasol Gmbh Particulas de lipidos a base de mezclas de lipidos liquidos y solidos asi como procedimiento para su produccion.
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents

Similar Documents

Publication Publication Date Title
JP2004515500A5 (ja)
JP2004523498A5 (ja)
JP2004529078A5 (ja)
JP2004532810A5 (ja)
JP2003213038A5 (ja)
JP2008512527A5 (ja)
RS52169B (en) STABLE LAKVINIMOD PREPARATIONS
JP2005503322A5 (ja)
JP2003520232A5 (ja)
JP2007505773A5 (ja)
JP2008531742A5 (ja)
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
JP2005518413A5 (ja)
JP2004525194A5 (ja)
JP2008515980A5 (ja)
JP2002053555A5 (ja)
JP2002506648A5 (ja)
JP2005535635A5 (ja)
JP2002506864A5 (ja)
CA2540225A1 (en) Solid preparation of pioglitazone, glimepiride and a polyoxyethylene sorbitan fatty acid ester
JP2002522501A5 (ja)
JP2002537232A5 (ja)
JP2005154531A5 (ja)
JP2005529175A5 (ja)
JP2004505922A5 (ja)